Skip to content
PICO Portalanswers from OpenAlex

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed

PaperCitations, authors & open-access status

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is a paper indexed in PICO Portal from OpenAlex.

How many citations does Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed have?

PICO Portalcitation count

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed has 189 citations in the OpenAlex counts PICO Portal stores.

When was Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed published?

PICO Portalyear

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed has 2016 year in the PICO Portal index.

What is the open-access status of Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

PICO Portaloa status

Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed has closed oa status in the PICO Portal index.

What is the DOI of Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

PICO Portaldoi

The DOI for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is on the source record.

What is the PMID of Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

PICO Portalpmid

The PMID for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is on the source record.

What is the OpenAlex record for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed?

PICO Portalopenalex

The OpenAlex for Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial